Growing community of inventors

Yorktown Heights, NY, United States of America

Thomas Craig Meagher

Average Co-Inventor Count = 3.82

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Thomas Craig MeagherEric L Smith (4 patents)Thomas Craig MeagherTong Zhang (4 patents)Thomas Craig MeagherChia-Yang Lin (4 patents)Thomas Craig MeagherJiaxi Wu (4 patents)Thomas Craig MeagherMaria Del Pilar Molina-Portela (4 patents)Thomas Craig MeagherDavid DiLillo (2 patents)Thomas Craig MeagherJessica Kirshner (1 patent)Thomas Craig MeagherFrank Delfino (1 patent)Thomas Craig MeagherOlga Sineshchekova (1 patent)Thomas Craig MeagherKevin A Bray (1 patent)Thomas Craig MeagherDavid Dilillo (1 patent)Thomas Craig MeagherDavid Dilillo (0 patent)Thomas Craig MeagherThomas Craig Meagher (7 patents)Eric L SmithEric L Smith (85 patents)Tong ZhangTong Zhang (21 patents)Chia-Yang LinChia-Yang Lin (18 patents)Jiaxi WuJiaxi Wu (6 patents)Maria Del Pilar Molina-PortelaMaria Del Pilar Molina-Portela (6 patents)David DiLilloDavid DiLillo (5 patents)Jessica KirshnerJessica Kirshner (29 patents)Frank DelfinoFrank Delfino (25 patents)Olga SineshchekovaOlga Sineshchekova (5 patents)Kevin A BrayKevin A Bray (4 patents)David DililloDavid Dilillo (1 patent)David DililloDavid Dilillo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Regeneron Pharmaceuticals, Inc. (7 from 1,342 patents)


7 patents:

1. 12319724 - IL2 agonists and methods of use thereof

2. 12291559 - Compositions and methods for treating cancer

3. 12215131 - IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof

4. 12150959 - Chimeric antigen receptors with BCMA specificity and uses thereof

5. 12091440 - IL2 and peptide-MHC complex fusion proteins and methods of use thereof

6. 11826386 - Compositions and methods for treating cancer

7. 11725034 - IL2 agonists and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…